ProCan Technologies leverages world-leading expertise, our technological and methods advancements, and our unique, powerful database with tens of thousands of clinically annotated cancer specimens to empower your pre-clinical research or clinical trials programs.

ProCan de-risks, accelerates and decreases the cost of oncology clinical trials

Research

Accelerate your research with customised, world-leading proteomics

TargetQuantTM ADC Panel

Unlock the power of proteomics for ADC Development

  • Full report detailing proteins of interest
  • List of proteins corresponding to the TSO500 gene list
  • Tailored Diagnostic/ Prognostic panels
  • Over 8K proteins identified enabling a search for novel targets
  • Ability to search for specific markers/targets